Magnesium Sulfate vs Placebo for Placental Abruption
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Sponsor: Santa Clara Valley Medical Center
This NA trial investigates Abruptio Placentae and is currently completed. Santa Clara Valley Medical Center leads this study, which shows 10 recorded versions since 2004 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Study Description(click to expand)We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.
We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2017 — Jan 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Mar 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Santa Clara Valley Medical Center
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .